<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="308318">
  <stage>Registered</stage>
  <submitdate>31/07/2009</submitdate>
  <approvaldate>21/08/2009</approvaldate>
  <actrnumber>ACTRN12609000720213</actrnumber>
  <trial_identification>
    <studytitle>A pilot study to investigate vitamin D status and its associations with dietary vitamin D intake, sunlight exposure and selected health outcomes in peritoneal dialysis and hemodialysis patients attending the Royal Brisbane and Women's Hospital renal unit.</studytitle>
    <scientifictitle>A pilot study to investigate vitamin D status and its associations with dietary vitamin D intake, sunlight exposure, kidney disease, bone disease, inflammation, metabolic syndrome and quality of life in peritoneal dialysis and hemodialysis patients.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Chronic Kidney Disease</healthcondition>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Kidney disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Vitamin D intake from diet and supplements for the previous month assessed by questionnaire. Sunlight exposure for the previous month assessed by questionnaire. Serum vitamin D concentration (25(OH)D on the day of dialysis clinic visit (peritoneal dialysis patients) or during their usual hemodialysis sessions (hemodialysis patients).</interventions>
    <comparator>Not applicable</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Malnutrition status - assessed using Patient Generated Subjective Global Assessment 
Body mass index - assessed using height &amp; dry weight measures
Energy and micro-nutrient intake - assessed using a 4day food diary completed over 7 days (including 1 weekend day)</outcome>
      <timepoint>Patient generated subjective global assessment - assessed at time of clinic visit.
Body mass index - assessed at time of clinic visit.

Energy &amp; micronutrient intake - assessed 4 days over a 7 day period following the clinic visit.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Dialysis duration - assessed from medical records
Dialysis adequacy - Assessed using urea clearance, dialysis time and total body water (Kt/V)
Estimated glomerular filtration rate - Assessed using serum creatinine, age and body weight
Potassium - serum potassium concentration analysis
Urea - serum urea concentration analysis
Albumin - serum albumin concentration analysis
Phosphate - serum phosphate concentration analysis
Calcium X phosphate - serum calcium X phosphate concentration analyses</outcome>
      <timepoint>Dialysis duration - assessed at time of clinic visit.
Dialysis adequacy - assessed at time of clinic visit over duration of dialysis - usually 4-5 hours
estimated Glomerular Filtration Rate - assessed at time of clinic visit.
Potassium - assessed at time of clinic visit.
Urea - assessed at time of clinic visit.
Phosphate - assessed at time of clinic visit.
Calcium X phosphate - assessed at time of clinic visit.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Markers of inflammation Pentraxin 3 - blood analysis C reactive protein- blood analysis Interleukin-6 - blood analysis Interleukin-10 - blood analysis Interleukin-12 - blood analysis Tumour-necrosis factor alpha - blood analysis asssessed in peritoneal dialysis patients.</outcome>
      <timepoint>Pentraxin 3, C reactive protein, Interleukin-6, Interleukin-10, Interleukin-12, Tumour-necrosis factor alpha - all assessed at time of clinic visit.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Kidney disease quality of life questionnaire score (KDQOL)</outcome>
      <timepoint>KDQOL  - assessed at time of clinic visit.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Bone status Bone morphogenic protein 7 - blood analysis Bone-specific alkaline phosphatase - blood analysis n-terminal cross-linking telopeptide of type I collagen - urine analysis Parathyroid hormone - blood analysis in peritoneal dialysis patients.</outcome>
      <timepoint>Bone morphogenic protein 7, Bone-specific alkaline phosphatase , n-terminal cross-linking telopeptide of type I collagen, Parathyroid hormone - all assessed at time of clinic visit for peritoneal dialysis patients.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Metabolic syndrome status 
Serum lipids - blood analysis
Urinary albumin - Urine analysis
Diabetes/prediabetes status - Medical records
Blood pressure - Mercury sphygmanometer</outcome>
      <timepoint>Serum lipids, Urinary albumin, Diabetes/prediabetes status, Blood pressure - all assessed at time of clinic visit.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Chronic kidney disease patients on peritoneal dialysis or hemodialysis Attending the home and independent dialysis unit at the Royal Brisbane and Women's Hospital</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Pregnant women
Patients unable to communicate in English
Patient lacking the cognitive ability to participate or give informed consent</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Convenience sample</selection>
    <timing>Both</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>11/08/2009</anticipatedstartdate>
    <actualstartdate>18/08/2009</actualstartdate>
    <anticipatedenddate />
    <actualenddate>8/12/2010</actualenddate>
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <hospital>Royal Brisbane &amp; Womens Hospital - Herston</hospital>
    <postcode>4029 - Royal Brisbane Hospital</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Queensland University of Technology</primarysponsorname>
    <primarysponsoraddress>Victoria Park Road
Kelvin Grove
Queensland 4059</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Queensland University of Technology</fundingname>
      <fundingaddress>Victoria Park Road
Kelvin Grove
Queensland 4059</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Royal Brisbane and Women's Hospital</fundingname>
      <fundingaddress>Butterfield Street
Herston
Queensland 4029</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Royal Brisbane and Women's Hospital</sponsorname>
      <sponsoraddress>Butterfield Street
Herston
Queensland 4029</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of the study is to investigate vitamin D and health in people with chronic kidney disease who are using peritoneal dialysis or hemodialysis. As part of the study we want to find out whether people using peritoneal dialysis have low vitamin D levels in their blood and how much vitamin D they get from food and sunlight exposure. We also want to find out whether low vitamin D is related to adverse health outcomes. Study hypotheses (alternative hypotheses) 1) Low intake of vitamin D &amp; exposure to sunlight will be associated with low blood levels of vitamin D 2) Low blood levels of vitamin D will be associated with adverse health outcomes</summary>
    <trialwebsite />
    <publication>Martensen, Renee, Ash, Susan, Healy, Helen, Fassett, Robert, Kimlin, Michael, Cardinal, John, et al. (2012) Vitamin D intake, sun exposure and 25-hydroxy vitamin D status in Peritoneal dialysis (PD) and Haemodialysis (HD) patients. Oral Presentation. 16th International Congress of Dietetics, 5-8 September 2012, Sydney Convention &amp; Exhibition Centre, Sydney, NSW.

</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Royal Brisbane and Women's Hospital Human Research Ethics Committee</ethicname>
      <ethicaddress>Level 7, Block 7
Royal Brisbane and Women's Hospital
Butterfield Street
Herston
Queensland 4029</ethicaddress>
      <ethicapprovaldate>3/09/2010</ethicapprovaldate>
      <hrec>09/QRBW/161</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Queensland University of Technology HUman Research Ethics Committee</ethicname>
      <ethicaddress>88 Musk Avenue
Queensland University of Technology
Kelvin Grove
Queensland 4059</ethicaddress>
      <ethicapprovaldate>16/07/2009</ethicapprovaldate>
      <hrec>0900000699</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Katherine Hanna</name>
      <address>School of Public Health
Queensland University of Technology
Victoria Park Road
Kelvin Grove
Queensland 4059</address>
      <phone>+61 7 3138 8202</phone>
      <fax />
      <email>k.hanna@qut.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Dr Katherine Hanna</name>
      <address>School of Exercise and Nutrition Sciences
Queensland University of Technology
Victoria Park Road 
Kelvin Grove QLD 4059</address>
      <phone>+ 61 7 3138 8202</phone>
      <fax />
      <email>k.hanna@qut.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Katherine Hanna</name>
      <address>School of Exercise and Nutrition Sciences
Queensland University of Technology
Victoria Park Road 
Kelvin Grove QLD 4059</address>
      <phone>+61 7 3138 8202</phone>
      <fax>+ 61 7 3138 3369</fax>
      <email>k.hanna@qut.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Susan Ash</name>
      <address>School of Exercise and Nutrition Sciences
Queensland University of Technology
Victoria Park Road 
Kelvin Grove QLD 4059</address>
      <phone>+61 07 3138 3524</phone>
      <fax />
      <email>s.ash@qut.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>